Efficacy of hydroxyethyl starch and Haemaccel for the treatment of severe ovarian hyperstimulation syndrome

Fertility and Sterility

Volumn 77, Issue 6, 2002, Pages 1302-1303

  Gamzu, Ronni ^a,b   Almog, Benny ^a   Levin, Yishai ^a   Avni, Amiram ^a   Lessing, Joseph B ^a   Baram, Amiram ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b LIS MATERNITY HOSPITAL   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

HETASTARCH; POLYGELINE;

COLLOID; DISEASE SEVERITY; DRUG EFFICACY; GERMANY; HEMATOCRIT; HEMODYNAMICS; HOSPITALIZATION; HUMAN; HYDROLYSIS; LETTER; LEUKOCYTE COUNT; MOLECULAR SIZE; MOLECULAR WEIGHT; OVARY DISEASE; OVARY HYPERSTIMULATION; PRIORITY JOURNAL; REDUCTION;

ADULT; FEMALE; HETASTARCH; HUMANS; OVARIAN HYPERSTIMULATION SYNDROME; PLASMA SUBSTITUTES; POLYGELINE; SEVERITY OF ILLNESS INDEX;

EID: 0036283508     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(02)03088-1     Document Type: Article

References (4)

1. The ovarian hyperstimulation syndrome
2. Reduced incidence of ovarian hyperstimulation syndrome by prophylactic infusion of hydroxyaethyl starch solution in an in-vitro fertilization programme
3. Prophylactic intravenous hydroxyethyl starch solution prevents moderate-severe ovarian hyperstimulation in in-vitro fertilization patients: A prospective, randomized, double-blind and placebo-controlled study
4. Hydroxyethylstarch versus human albumin for the treatment of severe ovarian hyperstimulation syndrome: A preliminary report